Elucid
Clinically validated medical-imaging software that analyzes CT angiography to characterize arterial plaque and help clinicians assess cardiovascular risk.
$55MSeries D
ParticipantEM
Elevage Medical Technologies
Activity from announced rounds
Activity in this selectionUnited States · Oct 16, 2026 · Jul 19, 2026
Elevage Medical Technologies is the investment organization whose official news identifies Nuclera, Imperative Care and Elucid.
Recorded funding activity
Elucid analyzes CT angiography to characterize arterial plaque. Nervonik develops peripheral nerve stimulation, while Imperative Care develops treatments for thromboembolic disease. These company records connect the organization to different diagnostic and treatment technologies.
- Rounds participated in
- 1
- Confirmed lead rounds
- 0 All roles disclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $55M 1 disclosed · full round size, not this investor’s share